Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes

Abstract

Immune profiles have been associated with bladder cancer outcomes and may have clinical applications for prognosis. However, associations of detailed immune cell subtypes with patient outcomes remain underexplored and may contribute crucial prognostic information for better managing bladder cancer recurrence and survival.

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2023
Source ID
10.1158/1055-9965.epi-23-0331

Entities

People

  • Angeline Andrew
  • Annette M Molinaro
  • Brock C Christensen
  • Devin C Koestler
  • Ji-Qing Chen
  • John D. Seigne
  • John K Wiencke
  • Karl Kelsey
  • Lucas A. Salas
  • Margaret Karagas

Organizations

  • Brown University
  • Congressionally Directed Medical Research Programs
  • Dartmouth College
  • Geisel School of Medicine
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Institutes of Health
  • University of California, San Francisco
  • University of Kansas

Tags

Fields of Study

  • Biology

Readers

  • Molecular and genetic basis of cancer.
  • Oncology